These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14001784)

  • 21. Non-thiol-activated cytolytic bacterial toxins: current status.
    Kato I; Morinaga N; Muneto R
    Microbiol Sci; 1988 Feb; 5(2):53-7. PubMed ID: 3152763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A haemagglutination test for anti-Panton-Valentine leucocidin in serum: an interim report on 200 cases.
    TOWERS AG
    J Clin Pathol; 1961 Mar; 14(2):161-3. PubMed ID: 13777770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The variability of Staphylococcus aureus under the influence of guinea-pig polymorphonuclear leukocytes].
    MESROBEANU I; TAGA S; ALEXENCO E; STAVRI D
    Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():579-89. PubMed ID: 14472954
    [No Abstract]   [Full Text] [Related]  

  • 24. The immunisation of rabbits with staphylococcal leucocidin toxoid. With a report on the pathological histology of their internal organs.
    Soucková-Stĕpánová J; Gladstone GP; Vanĕcek R
    Br J Exp Pathol; 1965 Aug; 46(4):384-407. PubMed ID: 5825774
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of staphylococcal leukocidins on human granulocytes].
    Georgadze TsV
    Biull Eksp Biol Med; 1969 Aug; 68(8):87-9. PubMed ID: 5401713
    [No Abstract]   [Full Text] [Related]  

  • 26. Panton-Valentine leucocidin associated Staphylococcus aureus infections.
    Etienne J; Dumitrescu O
    BMJ; 2009 Oct; 339():b4083. PubMed ID: 19837744
    [No Abstract]   [Full Text] [Related]  

  • 27. METABOLIC AND MORPHOLOGICAL CHANGES OF POLYMORPHONUCLEAR LEUCOCYTES DURING PHAGOCYTOSIS.
    ZATTI M; ROSSI F; MENEGHELLI V
    Br J Exp Pathol; 1965 Apr; 46(2):227-33. PubMed ID: 14286951
    [No Abstract]   [Full Text] [Related]  

  • 28. [Staphylococcus aureus producing Panton-Valentine leukocidin : notions in clinical practice].
    Pérez S; Liaudet A; Favrat B; Cornuz J; Greub G
    Rev Med Suisse; 2018 Oct; 14(625):1946-1950. PubMed ID: 30379477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding.
    Meyer F; Girardot R; Piémont Y; Prévost G; Colin DA
    Infect Immun; 2009 Jan; 77(1):266-73. PubMed ID: 18838523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric determination of Panton-Valentine leucocidin S component binding.
    Gauduchon V; Werner S; Prévost G; Monteil H; Colin DA
    Infect Immun; 2001 Apr; 69(4):2390-5. PubMed ID: 11254598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of flow cytometry in toxinology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus.
    Meunier O; Falkenrodt A; Monteil H; Colin DA
    Cytometry; 1995 Nov; 21(3):241-7. PubMed ID: 8582246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes.
    Russell RJ; Wilkinson PC; McInroy RJ; McKay S; McCartney AC; Arbuthnott JP
    J Med Microbiol; 1976 Nov; 9(4):433-9. PubMed ID: 12369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury.
    Diep BA; Chan L; Tattevin P; Kajikawa O; Martin TR; Basuino L; Mai TT; Marbach H; Braughton KR; Whitney AR; Gardner DJ; Fan X; Tseng CW; Liu GY; Badiou C; Etienne J; Lina G; Matthay MA; DeLeo FR; Chambers HF
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5587-92. PubMed ID: 20231457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reaction of rabbit leucocytes to staphylococcal (Panton-Valentine) leucocidin in vivo.
    Szmigielski S; Jeljaszewicz J; Wilczynski J; Korbecki M
    J Pathol Bacteriol; 1966 Apr; 91(2):599-604. PubMed ID: 4224060
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of a leukocidin identified in Staphylococcus pseudintermedius.
    Abouelkhair MA; Bemis DA; Giannone RJ; Frank LA; Kania SA
    PLoS One; 2018; 13(9):e0204450. PubMed ID: 30261001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly of staphylococcal leukocidin into a pore-forming oligomer on detergent-resistant membrane microdomains, lipid rafts, in human polymorphonuclear leukocytes.
    Nishiyama A; Kaneko J; Harata M; Kamio Y
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1300-7. PubMed ID: 16794307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methicillin-resistant Staphylococcus aureus (Panton-Valentine leucocidin) cavitating pneumonia in a healthy child.
    Gadelsayed MN; Greally P; Elnazir B
    Arch Dis Child; 2012 Nov; 97(11):980-1. PubMed ID: 22734016
    [No Abstract]   [Full Text] [Related]  

  • 38. Above and beyond C5a Receptor Targeting by Staphylococcal Leucotoxins: Retrograde Transport of Panton-Valentine Leucocidin and γ-Hemolysin.
    Zimmermann-Meisse G; Prévost G; Jover E
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28117704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcal leukocidin.
    Woodin AM
    Ann N Y Acad Sci; 1965 Jul; 128(1):152-64. PubMed ID: 5216755
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunofluorescent demonstration of staphylococcal leucocidin components F and S.
    Gershon A; Gladstone GP
    Br J Exp Pathol; 1968 Oct; 49(5):477-95. PubMed ID: 4178108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.